Viewing Study NCT00543504


Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2026-01-04 @ 6:11 AM
Study NCT ID: NCT00543504
Status: COMPLETED
Last Update Posted: 2020-06-30
First Post: 2007-10-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab in Multiple Phase I Combinations
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module